| AJCC | American Joint Committee on Cancer |
| AUC | Area under the curve |
| CBC | Complete blood count |
| ccRCC | Clear cell renal cell carcinoma |
| CRP | C-reactive protein |
| CT | Computed tomography |
| FDG-PET | Fluorodeoxyglucose-positron emission tomography |
| H&E | Hematoxylin and eosin |
| ICI | Immune checkpoint inhibitor |
| LDH | Lactate dehydrogenase |
| LPN | Laparoscopic partial nephrectomy |
| LRN | Laparoscopic radical nephrectomy |
| MRI | Magnetic resonance imaging |
| NSS | Nephron-sparing surgery |
| OPN | Open partial nephrectomy |
| ORN | Open radical nephrectomy |
| OS | Overall survival |
| PD-1 | Programmed death 1 |
| PD-L1 | Programmed death ligand 1 |
| PFS | Progression-free survival |
| PN | Partial nephrectomy |
| PNS | Paraneoplastic syndrome |
| RAPN | Robotic-assisted partial nephrectomy |
| RARN | Robotic-assisted radical nephrectomy |
| RCC | Renal cell carcinoma |
| RN | Radical nephrectomy |
| RNS | RENAL nephrometry score |
| RR | Relative risk |
| TKI | Tyrosine kinase inhibitor |
| TMN | Tumor, Node, and Metastasis |
| TSC | Tuberous sclerosis complex |
| US | Ultrasonography |
| VEGF | Vascular endothelial growth factor |
| VHL | Von Hippel–Lindau gene |